Affordable Access

Publisher Website

The treatment of pertussis with lyophile hyperimmune human pertussis serum

Authors
Journal
The Journal of Pediatrics
0022-3476
Publisher
Elsevier
Publication Date
Volume
25
Issue
1
Identifiers
DOI: 10.1016/s0022-3476(44)80191-3
Disciplines
  • Medicine

Abstract

Summary 1. Twenty-three patients with pertussis were treated with lyophile hyperimmune human pertussis serum. 2. Twelve of the patients treated were in the 1-to 3-month age group. Seventy-five per cent of these infants had a good response. There were no deaths in this group. 3. Treatment early in the course of pertussis was effective. In addition, two patients treated in the eighth and ninth week of illness had a good response. 4. There were demonstrable circulating agglutinins following the administration of the serum. 5. The lymphocytosis of the blood was suppressed after the administration of the serum. 6. Eleven patients who had pneumonic involvement were treated with the serum in addition to sulfadiazine. 7. There was no extension or recurrence of the pulmonary involvement and no development of pneumonia after a full course of serum therapy.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

[Human hyperimmune serum in the treatment of pertu...

on Helvetica paediatrica acta December 1950

[Human hyperimmune serum in pertussis].

on Nordisk medicin May 12, 1950

On the Use of Concentrated Pooled Human Serum and...

on Canadian Medical Association j... May 1941

Studies with H. Pertussis:VII. Preparation and ass...

on The Journal of Pediatrics Jan 01, 1941
More articles like this..